Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANVS
#3484
Annovis Bio, Inc.
2.6
9
-2.54%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-2.54%
Monthly Change
-9.12%
6 month change
+14.47%
Cambio anual
+46.20%
Cierres anteriores
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volumen
28
Markets
Acciones
Atención Sanitaria
ANVS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Director de Annovis Bio, Hoffman, compra acciones por $193,794
Director de Annovis Bio, Hoffman, compra acciones por 193.794 dólares
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Director de Annovis Bio, Hoffman, compra $69.9k en acciones de ANVS
El director de Annovis Bio, Hoffman, compra acciones de ANVS por 69.900 dólares
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Director de Annovis Bio compra acciones por $31,649
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)